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Abstract
Background: To assess the accuracy of fractionated stereotactic radiotherapy (FSRT) using a stereotactic mask
fixation system.
Patients and Methods: Sixteen patients treated with FSRT were involved in the study. A commercial stereotactic
mask fixation system (BrainLAB AG) was used for patient immobilization. Serial CT scans obtained before and
during FSRT were used to assess the accuracy of patient immobilization by comparing the isocenter position. Daily
portal imaging were acquired to establish day to day patient position variation. Displacement errors along the
different directions were calculated as combination of systematic and random errors.
Results: The mean isocenter displacements based on localization and verification CT imaging were 0.1 mm (SD 0.3
mm) in the lateral direction, 0.1 mm (SD 0.4 mm) in the anteroposterior, and 0.3 mm (SD 0.4 mm) in craniocaudal
direction. The mean 3D displacement was 0.5 mm (SD 0.4 mm), being maximum 1.4 mm. No significant
differences were found during the treatment (P = 0.4). The overall isocenter displacement as calculated by 456
anterior and lateral portal images were 0.3 mm (SD 0.9 mm) in the mediolateral direction, -0.2 mm (SD 1 mm) in
the anteroposterior direction, and 0.2 mm (SD 1.1 mm) in the craniocaudal direction. The largest displacement of
2.7 mm was seen in the cranio-caudal direction, with 95% of displacements < 2 mm in any direction.
Conclusions: The results indicate that the setup error of the presented mask system evaluated by CT verification
scans and portal imaging are minimal. Reproducibility of the isocenter position is in the best range of positioning
reproducibility reported for other stereotactic systems.
Introduction
Stereotactic radiation techniques in form of radiosurgery
(SRS) or fractionated stereotactic radiotherapy (FSRT)
are frequently employed in patients with skull base
tumors in order to increase the precision of radiother-
apy and decrease the potential long-term toxicity of
treatment [1-3].
FSRT using a commercially available stereotactic mask
fixation system (BrainLAB AG) has been routinely used
at University Hospital Sant’Andrea in patients with skull
base tumors since 2006. Differing from SRS, where
patients are usually immobilized by an invasive
stereotactic frame and radiation is given in a one large
dose, patients undergoing FSRT are immobilized in a
high precision relocatable noninvasive frame, so that it
is possible to administrate stereotactic irradiation in a
number of small doses/fractions. So far, FSRT combines
the precision of stereotactic technique with the biologi-
cal advantages of conventional radiotherapy.
Different frameless stereotactic systems, including
infrared camera guidance [4], dental [5-11], implanted
fiducial markers [12,13], and mask fixation system
[14-20] have been developed in the last two decades. An
essential prerequisite of a frameless system is that
patient fixation and positioning are performed with a
high degree of accuracy in order to delivery a safe thera-
peutic radiation dose. Accuracy of patient positioning
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using both CT and portal images as in current use in
our department is reported and discussed.
Methods and materials
The commercially available frameless BrainLAB stereo-
tactic system in conjunction with the BrainScan 5.1
planning system has been used for stereotactic irradia-
tion. Sixteen patients treated with FSRT were involved
in the study. The cases included 8 meningiomas, 6 pitui-
tary adenomas and 2 craniopharyngiomas. All patients
gave their consent to the study.
The target volume was identified on the basis of the
fused CT and magnetic resonance (MR) images. The
gross tumor volume (GTV) was delineated as a con-
trast-enhancing tumor demonstrated on MRI scans.
CTV was considered the same as GTV. The planning
target volume (PTV) was generated by the geometric
expansion of CTV plus 4 mm. Treatment volumes were
achieved with 5-8 noncoplanar beams shaped using a
micromultileaf collimator (MLC). All patients were trea-
ted on a 6-MV LINAC with a 120 leaf MLC (Varian
Clinac 600 DBX). Treatment dose varied between 45
and 55 Gy in 25-33 fractions over 5-6 and 1/2 weeks.
FSRT procedure
The general procedure for FSRT consisted of different
phases: - mask fixation; - CT localization; - treatment
planning, - and CT verification. The commercial Brain-
Lab mask fixation system (Figure 1) consisted of - a
semicircular metal frame; - an upper and a lower mask
conformed to the anterior (fronto-zygomatic area) and
posterior surfaces (occipital and neck curvature) of
head; - two lateral carbon bars for fixing the thermo-
plastic mask; - a mouth bite which is applied to the
patient’s upper dentition to avoid any head tilt move-
ment, - and a plastic head rest. An extra rigid strip of
plastic is applied across the nose-bridge, underneath the
upper mask, to avoid any head rotation. Following fabri-
cation the patient remained in the mask for 30 minutes
to minimize the potential thermoplastic shrinkage dur-
ing cool.
During the CT localization, a localizer box was
mounted to the BrainLAB mask system in order to pro-
vide a three-dimensional (3D) stereotactic coordinate
array for target localization. The patient is laid on the
CT couch with the system secured onto a custom-made
platform. CT imaging was performed using the GE 16-
slice scanner. CT (General Electric Medical System)
scaning was done in spiral mode using a pitch of 0.75,
and slices in thickness and spacing of 1.2 mm acquired
t h r o u g h o u tt h ee n t i r ec r a n i u m .T u b ev o l t a g ea n dt u b e
potential were set at 130 kV and 300 mA to obtain high
quality 1.2 mm reconstructed slices.
CT localization set was imported into the planning
system (BrainScan) and stereotactic localization was per-
formed by the software by identifying the location of six
localizer rods on the outside surfaces of the right, left,
and anterior walls of the localizer box. Localization
establishes the 3D stereotactic coordinate system for
treatment planning and delivery. After volume contour-
ing, treatment planning and optimization, the patient
began the treatment. During treatment, a target posi-
tioner box permitted to align patients to the treatment
position. The target positioner box consisted of a skele-
tal aluminium box attached onto the mask system. The
position of the treatment isocenter and the shapes of
the beam projections were generated on four pieces of
transparency by the planning system, and were attached
to the anterior, superior and lateral sides of the target
positioner box to mark the isocenter. The patients were
then positioned in the treatment room by aligning the
isocenter of the target positioner box with the room
lasers.
T h ea c c u r a c yo fp a t i e n t ’s head immobilization with
the stereotactic mask was assessed by serial CT scans by
comparing the isocenter position between CT localiza-
tion and CT verification. CT verification scans in the
frame were taken immediately before and every 2 weeks
during the treatment using slices in thickness and spa-
cing of 1.2 mm acquired throughout the entire cranium.
CT localization and CT verification were fused
employing a fusion algorithm included in the BrainLAB
planning system and the isocenter shift calculated [21].
Firstly, the verification CT set is imported in the plan-
ning system and localized automatically by the planning
software through identification of the stereotactic fidu-
cials. Since this step defines the stereotactic coordinates
of all brain structures with the respect to the localizer
Figure 1 Patient with mask fixation. The system consists of a
semicircular metal frame, an upper and a lower mask conformed to
the anterior and posterior surfaces of head, two lateral carbon bars
for fixing the thermoplastic mask, and a mouth bite.
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match of isocenter. In the second step the localization
CT (planning CT) and verification CT scans were fused,
and the anatomy co-registered using the CT verification
as reference CT. Finally, the new coordinates of the iso-
center were recorded, and isocenter shift between verifi-
cation and planning CT calculated. Deviations of
isocenter coordinates in each direction were measured
as mean ± standard deviation (SD) for all patients. The
3D displacement determined by the square root of the
sum of squares of the displacements seen in the 3 direc-
tions was calculated. The amount of isocenter shift of
serial CT scans was assessed using analysis of variance
(ANOVA) for repeated measures.
During CT localization and CT verification 3 radiopa-
que markers were positioned outside the surface of the
localizer box and aligned with both anterior and lateral
lasers in order to reproduce the patient position. This
alignment permits to assess the repositioning accuracy
of BrainLAB mask by evaluating the shift of isocenter
position between CT localization (planning CT) and CT
verification in relation to anatomical skull base cranial
structures directly on CT slices using the GE 16-slice
scanner CT console, and this procedure is currently
used in clinical practice before stereotactic treatments
(Figure 2).
Treatment set-up and verification by portal imaging
Before treatment, anteroposterior and right lateral radio-
graphs were generated in the simulator room and
exported to the Portal Vision® (Varian Medical Systems,
Palo Alto, Ca, USA) to be used as reference images.
Five-six points for anatomy matching were drawn on
the reference images, including superior orbital ridge
and roof, pituitary fossa, frontal and occipital bones.
Patients in both simulator and treatment room were
Figure 2 Verification of isocenter position accuracy. During CT localization (A) and CT verification (B) the patient is positioned on the CT
couch with the target positioner box aligned with anterior and lateral lasers using the radio-opaque markers (arrows). The amount of isocenter
shift between CT localization (planning CT) (C) and CT verification (D) in relation to anatomical skull base cranial structures was then evaluated
directly on the CT scans.
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tioner box with the room lasers.
Daily portal images 9.6 × 9.6 cm acquired at 0 and 90°
through the isocenter were obtained for each patient
during the treatment for a total of 456 portal pair
images. Portal and reference images were aligned by
automatic matching (Varian portal Vision. 6.0). In the
first step the field edge on portal image is automatically
matched with the field aperture of the reference images,
regardless of the anatomy and the points for matching.
Then, the system aligns the portal and the reference
images anatomically according to the defined points on
the match anatomy layers. The patient misalignment
visible as the difference between detected and planned
field edges was automatically calculated. Matching was
also reviewed and manually adjusted as appropriate by
an experienced radiotherapist to give the best possible
alignment using the visible anatomy.
Displacements along mediolateral, anterioposterior,
craniocaudal direction, and 3D displacement were calcu-
lated. Displacement errors along the different directions
were investigated as overall, systematic, and random
errors according to previous reports [22], and as also
recognized by the ICRU-62 report [23]. The systematic
error, which describes the persistent positioning varia-
tion for an individual patient, was assessed by the SD of
the mean value of the displacement along a given axis.
Random errors, which are represented by day-to-day
variation of displacements for individual patient, were
assessed by subtraction of the systematic displacement
from the observed displacement. For the whole popula-
tion, the distribution of the random component displa-
cements was determined by calculating the SD of all
individual random values. Overall displacement for each
direction is a combination of both systematic and ran-
dom errors, and was determined by the square root of
the sum of squares of the SD of systematic and random
error.
Quality control procedures at the CT scanner, simula-
tion room and linear accelerator were performed. The
accuracy of coincidence of the radiation isocenter of the
treatment unit and the laser-defined room coordinate
system for patient alignment (TC scanner, simulator
and treatment rooms) resulted within 1 mm.
Results
CT verification
Sixteen patients were evaluated in the study for a total
of 64 verification CT scans. The relocation accuracy of
the isocenter determined from the CT verification
before the treatment is shown in Table 1. The mean
measured isocenter displacements were 0.1 mm (SD 0.3
mm) in the lateral direction, 0.1 mm (SD 0.4 mm) in
the anteroposterior, and 0.3 mm (SD 0.4 mm) in
craniocaudal direction. The maximum displacement of
1.0 mm was seen in craniocaudal direction. The mean
3D displacement was 0.5 mm (SD 0.4 mm), being maxi-
mum 1.4 mm. Translational isocenter movements calcu-
lated during the treatment showed no significant
differences in patient reproducibility (P = 0.4) (Table 1).
Overall, patient reproducibility during the treatment
showed maximum displacement of 1.2 mm in any direc-
tion, and 3D displacement < 1.5 mm.
Portal imaging
The mean and SD of treatment setup errors for all
patients as measured from portal imaging are summar-
ized in Table 2. The systematic, random and overall SD
components of isocenter displacements along the med-
ioateral, anterior-posterior and cranial-caudal directions
are reported along with the 3D displacement. The over-
all displacements of the isocenter were 0.3 mm (SD 0.9
mm) in the mediolateral direction, -0.2 mm (SD 1 mm)
in the anteroposterior direction, and 0.2 mm (SD 1.1
mm) in the craniocaudal direction. The largest overall
displacement of 2.7 mm was seen in the craniocaudal
direction, with 95% of displacements < 2 mm in any
direction. Mean and SD of rotation errors in coronal
and sagittal planes were 0.02° (SD 0.6°) and 0.03° (SD
0.5°), respectively. The mean 3D displacement was 1.5
mm with a mean SD of 0.5 mm (ranging from 0.2 to 2.8
mm).
Table 1 Positioning deviations of isocenter relocation at
CT verification before and during radiation treatment.
pre-
treatment
2 weeks 4 weeks end of
treatment
Direction (mm) mean (SD) mean
(SD)
mean
(SD)
mean (SD)
Craniocaudal 0.3 (0.4) 0.3 (0.5) 0.3 (0.6) 0.4 (0.5)
Mediolateral 0.1 (0.3) 0.1 (0.4) 0.2 (0.4) 0.2 (0.4)
Anteroposterior 0.1 (0.4) 0.2 (0.4) 0.2 (0.4) 0.2 (0.5)
3D-
displacement
0.5 (0.4) 0.5 (0.4) 0.6 (0.4) 0.6 (0.5)
SD, standard deviation
Table 2 Mean and standard deviation of overall,
systematic, and random setup errors at portal images
during the treatment (n = 456)
Distribution of
displacements (1 SD, mm)
Overall
displacement
(mm)
Overall
(n =
456)
Systematic
(n = 16)
Random
(n = 456)
Mediolateral 0.3 0.9 0.7 0.5
Anteroposterior -0.2 1 0.8 0.6
Craniocaudal 0.2 1.1 0.9 0.7
SD, standard deviation
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Accuracy and reproducibility of patient repositioning is
mandatory for FSRT. Several non-invasive stereotactic
fixation systems have been developed based on masks
[14-20], bite blocks [5-11] or infrared camera guidance
[4]. We used a commercial stereotactic system based on
a thermoplastic mask, assessing the accuracy of isocen-
ter relocation by serial CT scans and portal imaging.
The accuracy of isocenter relocation evaluated by fusion
between localization and verification CT scans was less
than 1.5 mm, with the largest displacement of 1.2 seen
in the cranial-caudal direction. Notably, the accuracy
was maintained over the 6 weeks treatment, suggesting
that is appropriate to consider an isocenter shift within
2 mm during the planning process. In our study the cal-
culation of isocenter displacement was based on fused
CT images, however the accuracy of patient immobiliza-
tion was also evaluated by manually superimposing the
verified CT onto the reference CT using the brain struc-
tures [18]. We obtained a maximum displacement of 1.5
mm in any direction (data not shown), and currently
this procedure is routinely employed in our department
before stereotactic treatments.
Although results from different studies are difficult to
compare because of different measuring and statistical
methods applied, our positioning data are in the same
range or better than other non-invasive fixation systems
[5-20]. A number of studies reported on the accuracy of
similar mask fixation systems evaluated by CT verifica-
tion [5,6,10,11,14-16,18,19]. Using the BrainLAB stereo-
tactic mask fixation system Wong et al. [18] reported a
mean and maximum 3D displacements at the isocenter
of 0.7 and 2.5 mm, respectively. Willner et al [15]
reported a mean 3D displacement of 2.4 mm and SD of
1.3 mm, and similar results have been shown by others
[6,14,16,19]. Using a bite block immobilization Kumar et
al [11] reported an accuracy of isocenter relocation at
CT verification of 0.7 mm, with a range between 0.1-1.4
mm, being similar to previous reported studies from the
Royal Marsden [5,6,9]. So far, as for other radiotherapy
units, CT verification represents an essential part of our
FSRT quality assurance and is routinely used in our
institution.
Since patient relocation evaluated by comparison of
localization and verification CT scans does not include
errors which are related to the treatment unit as laser
alignment, machine and couch accuracy, we have evalu-
ated setup accuracy by daily portal images. Orthogonal
simulator images through isocenter were used as refer-
ence images because the advantage of sharp contrast.
Mean and SD of displacements for each direction, were
0.3 mm (SD 1 mm) in the mediolateral direction, -0.2
mm (SD 1 nm) in the anteroposterior direction, and 0.3
mm (SD 1.2 mm) in the craniocaudal direction. The
mean 3D displacement was 0.44 mm (SD 1.9 mm), ran-
ging from 0.2 to 2.8 mm. Rotational movements devia-
tions on coronal and sagittal planes showed only
minimal rotational errors. A similar maximum mean
rotation in the repositioning accuracy of FSRT in any
direction less than 0.6 degrees has been reported by sev-
eral authors using either mask or bite fixation system
[10,11,17,18]. Minor rotational deviations for tumors in
central parts of the head as in our study are associated
with smaller isocenter shift than for tumors located in
posterior fossa or lateral parts of brain, and significant
changes of isocenter position are unlikely [24].
In the ICRU-62 report the overall standard deviation
for PTV margin calculation is determined by quadrati-
cally adding SD for systematic errors in the patient
group (Σ) and SD of distribution of the random errors
(s), although different models to calculate geometric
uncertainties have been proposed [25,26]. Applying the
formula CTV-to-PTV margin = 2 Σ + 0.7 s as proposed
by Stroom et al [25] we obtained a maximum value of
2.3 mm. The criterion to derive this recipe was that on
average more than 99% of the CTV should at least get
95% of the dose. Van Herk et al. [26] defined a similar
margin recipe for the CTV to PTV expansion (2.5 Σ +
0.7 s) based on absorbed dose to CTV, equivalent uni-
form dose and tumor control probability. Applying this
formula we found a value of 2.8 mm.
According to the reported results, currently in our
clinical practice we use am a r g i nf r o mG T Vt oP T V
expansion of 3 mm, following the above protocol. If no
setup error greater than 2 mm in any one direction by
portal imaging is observed during the first week, ima-
ging will take place thrice a week for the remainder of
the course. If an error more than 2 mm occurs, portal
images are acquired on daily basis. In case of persistent
errors patient is re-planned and margin between GTV
and PTV increased from 3 to 4 mm. Larger systematic
errors more than 3 mm would necessitate a repeat of
the entire planning process.
Conclusion
In conclusion, the reproducibility of the isocenter using
the present mask fixation system is in the best range of
positioning accuracy reported for other non-invasive
fixation system for fractionated stereotactic irradiation.
CT verification scans to estimate setup reproducibility
result in high accuracy of isocenter relocation and is
essential part of our FSRT quality assurance. Portal ima-
ging which include couch, laser alignment and machine
errors confirms the accuracy of mask fixation system
showing a mean 3D setup error of 1.5 mm with a SD of
0.5 mm. A margin from GTV to PTV expansion of 3
mm seems appropriate to compensate for all possible
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practice.
Acknowledgements
We are grateful to Mr. Davide Mollo for his excellent technical assistance
during the study.
Author details
1Department of Radiation Oncology, Sant’ Andrea Hospital, University “La
Sapienza”, via di Grottarossa 1035-1039, 00189, Rome, Italy.
2Department of
Neuroscience, NEUROMED Institute, via Atinense 18, 86077, Pozzilli (IS), Italy.
3Department of Physics, Sant’ Andrea Hospital, University “La Sapienza”, via
di Grottarossa 1035-1039, 00189, Rome, Italy.
Authors’ contributions
GM conceived of the study, participated in its design and coordination, and
drafted the manuscript. MV and EC participated in study design, analysis and
interpretation of data, and helped to draft the manuscript.
MDA and MC performed the statistical analysis and carried out all CT
evaluations. RM and FS participated in acquisition and analysis of data. RME
critically reviewed/revised the article. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 1 September 2009
Accepted: 13 January 2010 Published: 13 January 2010
References
1. Brada M, Ajithkumar TV, Minniti G: Radiosurgery for pituitary adenomas.
Clin Endocrinol (Oxf) 2004, 61:531-543.
2. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M: Fractionated
stereotactic conformal radiotherapy for secreting and nonsecreting
pituitary adenomas. Clin Endocrinol (Oxf) 2006, 64:542-548.
3. Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, Ashley S,
Warrington J, Burke K, Mosleh-Shirazi A, Brada M: Fractionated stereotactic
conformal radiotherapy following conservative surgery in the control of
craniopharyngiomas. Radiother Oncol 2007, 82:90-95.
4. Buatti JM, Bova FJ, Friedman WA, Meeks SL, Marcus RB Jr, Mickle JP, Ellis TL,
Mendenhall WM: Preliminary experience with frameless stereotactic
radiotherapy. Int J Radiat Oncol Biol Phys 1998, 42:591-599.
5. Gill SS, Thomas DG, Warrington AP, Brada M: Relocatable frame for
stereotactic external beam radiotherapy. Int J Radiat Oncol Biol Phys 1991,
20:599-603.
6. Graham JD, Warrington AP, Gill SS, Brada M: A non-invasive, relocatable
stereotactic frame for fractionated radiotherapy and multiple imaging.
Radiother Oncol 1991, 21:60-62.
7. Laing RW, Thompson V, Warrington AP, Brada M: Feasibility of patient
immobilization for conventional cranial irradiation with a relocatable
stereotactic frame. Br J Radiol 1993, 66:1020-1024.
8. Kooy HM, Dunbar SF, Tarbell NJ, Mannarino E, Ferarro N, Shusterman S,
Bellerive M, Finn L, McDonough CV, Loeffler JS: Adaptation and
verification of the relocatable Gill-Thomas-Cosman frame in stereotactic
radiotherapy. Int J Radiat Oncol Biol Phys 1994, 30:685-691.
9. Warrington AP, Laing RW, Brada M: Quality assurance in fractionated
stereotactic radiotherapy. Radiother Oncol 1994, 30:239-246.
10. Rosenthal SJ, Gall KP, Jackson M, Thornton AF Jr: A precision cranial
immobilization system for conformal stereotactic fractionated radiation
therapy. Int J Radiat Oncol Biol Phys 1995, 33:1239-1245.
11. Kumar S, Burke K, Nalder C, Jarrett P, Mubata C, A’Hern R, Humphreys M,
Bidmead M, Brada M: Treatment accuracy of fractionated stereotactic
radiotherapy. Radiother Oncol 2005, 74:53-59.
12. Jones D, Christopherson DA, Washington JT, Hafermann MD, Rieke JW,
Travaglini JJ, Vermeulen SS: A frameless method for stereotactic
radiotherapy. Br J Radiol 1993, 66:1142-1150.
13. Kim KH, Cho MJ, Kim JS, Song CJ, Song SH, Kim SH, Myers L, Kim YE:
Isocenter accuracy in frameless stereotactic radiotherapy using
implanted fiducials. Int J Radiat Oncol Biol Phys 2003, 56:266-273.
14. Pilipuf MN, Goble JC, Kassell NF: A noninvasive thermoplastic head
immobilization system. Technical note. J Neurosurg 1995, 82:1082-1085.
15. Willner J, Flentje M, Bratengeier K: CT simulation in stereotactic brain
radiotherapy–analysis of isocenter reproducibility with mask fixation.
Radiother Oncol 1997, 45:83-88.
16. Alheit H, Dornfeld S, Dawel M, Alheit M, Henzel B, Steckler K, Blank H,
Geyer P: Patient position reproducibility in fractionated stereotactically
guided conformal radiotherapy using the BrainLab mask system.
Strahlenther Onkol 2001, 177:264-268.
17. Karger CP, Jakel O, Debus J, Kuhn S, Hartmann GH: Three-dimensional
accuracy and interfractional reproducibility of patient fixation and
positioning using a stereotactic head mask system. Int J Radiat Oncol Biol
Phys 2001, 49:1493-1504.
18. Wong VY, Tung SY, Leung TW, Ho KH: CT verification of isocentre
relocatability using stereotactic mask fixation system. Clin Oncol (R Coll
Radiol) 2003, 15:280-287.
19. Baumert BG, Egli P, Studer S, Dehing C, Davis JB: Repositioning accuracy of
fractionated stereotactic irradiation: assessment of isocentre alignment
for different dental fixations by using sequential CT scanning. Radiother
Oncol 2005, 74:61-66.
20. Solberg TD, Medin PM, Mullins J, Li S: Quality assurance of immobilization
and target localization systems for frameless stereotactic cranial and
extracranial hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys
2008, 71:S131-135.
21. Robar JL, Clark BG, Schella JW, Kim CS: Analysis of patient repositioning
accuracy in precision radiation therapy using automated image fusion.
2005, 6:71-83.
22. Bel A, Keus R, Vijlbrief RE, Lebesque JV: Setup deviations in wedged pair
irradiation of parotid gland and tonsillar tumors, measured with an
electronic portal imaging device. Radiother Oncol 1995, 37:153-159.
23. International Commission on Radiation Units and Measurements. ICRU
Report 62. Prescribing, recording, and reporting photon beam therapy
(Supplement to ICRU Report 50). Bethesda, MD:ICRU 1999.
24. Hodapp N, Nanko N, Rohner F, Frommhold H: Quality assurance for non-
invasive patient fixation during stereotactic convergent beam
irradiation. Acta Neurochir Suppl 1994, 62:101-104.
25. Stroom JC, Heijmen BJM: Geometrical uncertainties, radiotherapy
planning margins, and the ICRU-62 report. Radiother Oncol 2002, 64:75-83.
26. van Herk M, Bruce A, Kroes AP, Shouman T, Touw A, Lebesque JV:
Quantification of organ motion during conformal radiotherapy of the
prostate by three dimensional image registration. Int J Radiat Oncol Biol
Phys 1995, 33:1311-1320.
doi:10.1186/1748-717X-5-1
Cite this article as: Minniti et al.: Fractionated stereotactic radiotherapy
for skull base tumors: analysis of treatment accuracy using a
stereotactic mask fixation system. Radiation Oncology 2010 5:1.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Minniti et al. Radiation Oncology 2010, 5:1
http://www.ro-journal.com/content/5/1/1
Page 6 of 6